Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose F Camargo

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Clinical Transplantation|March 14, 2019
Clinical outcomes in HIV+/HCV+ coinfected kidney transplant recipients in the pre- and post-direct-acting antiviral therapy eras: 10-Year single center experienceJose F Camargo, Shweta Anjan, Nafeesa Chin-Beckford, et al.
F1000Research|March 17, 2017
Impact of antiretroviral therapy on clinical outcomes in HIV <sup>+</sup> kidney transplant recipients: Review of 58 casesRossana Rosa, Jose F Suarez, Marco A Lorio, et al.
Cureus|July 3, 2026
Refractory and/or Resistant Herpes Simplex Virus Mucocutaneous Infections in Adult Transplantation and Cellular Therapy Patients: A Single-Center ExperienceJoseph I Berger, Anthony D Anderson, Octavio V Martinez, et al.
Blood Advances|June 5, 2024
Incidence and outcomes of cytomegalovirus reactivation after chimeric antigen receptor T-cell therapyRick Y Lin, Anthony D Anderson, Yoichiro Natori, et al.
JAMA Internal Medicine|November 25, 2014
Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individualsJason F Okulicz, Tuan D Le, Brian K Agan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 9, 2017
Impact of Cytomegalovirus Viral Load on Probability of Spontaneous Clearance and Response to Preemptive Therapy in Allogeneic Stem Cell Transplantation RecipientsJose F Camargo, Erik Kimble, Rossana Rosa, et al.
Nature Medicine|April 1, 2008
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individualsSunil K Ahuja, Hemant Kulkarni, Gabriel Catano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2018
Linezolid- and Vancomycin-resistant Enterococcus faecium in Solid Organ Transplant Recipients: Infection Control and Antimicrobial Stewardship Using Whole Genome SequencingLilian Abbo, Bhavarth S Shukla, Amber Giles, et al.
Mycopathologia|February 5, 2026
Clinical Characteristics and Outcomes of Invasive Aspergillosis in Patients with Hematological Malignancies and Transplantation and Cellular Therapies in the Contemporary EraChristopher M Lopez, Jose F Suarez, Maria A Mendoza, et al.
Nature Immunology|October 24, 2007
CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanismsMatthew J Dolan, Hemant Kulkarni, Jose F Camargo, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Clinical Transplantation|March 14, 2019
Clinical outcomes in HIV+/HCV+ coinfected kidney transplant recipients in the pre- and post-direct-acting antiviral therapy eras: 10-Year single center experienceJose F Camargo, Shweta Anjan, Nafeesa Chin-Beckford, et al.
F1000Research|March 17, 2017
Impact of antiretroviral therapy on clinical outcomes in HIV <sup>+</sup> kidney transplant recipients: Review of 58 casesRossana Rosa, Jose F Suarez, Marco A Lorio, et al.
Cureus|July 3, 2026
Refractory and/or Resistant Herpes Simplex Virus Mucocutaneous Infections in Adult Transplantation and Cellular Therapy Patients: A Single-Center ExperienceJoseph I Berger, Anthony D Anderson, Octavio V Martinez, et al.
Blood Advances|June 5, 2024
Incidence and outcomes of cytomegalovirus reactivation after chimeric antigen receptor T-cell therapyRick Y Lin, Anthony D Anderson, Yoichiro Natori, et al.
JAMA Internal Medicine|November 25, 2014
Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individualsJason F Okulicz, Tuan D Le, Brian K Agan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 9, 2017
Impact of Cytomegalovirus Viral Load on Probability of Spontaneous Clearance and Response to Preemptive Therapy in Allogeneic Stem Cell Transplantation RecipientsJose F Camargo, Erik Kimble, Rossana Rosa, et al.
Nature Medicine|April 1, 2008
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individualsSunil K Ahuja, Hemant Kulkarni, Gabriel Catano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2018
Linezolid- and Vancomycin-resistant Enterococcus faecium in Solid Organ Transplant Recipients: Infection Control and Antimicrobial Stewardship Using Whole Genome SequencingLilian Abbo, Bhavarth S Shukla, Amber Giles, et al.
Mycopathologia|February 5, 2026
Clinical Characteristics and Outcomes of Invasive Aspergillosis in Patients with Hematological Malignancies and Transplantation and Cellular Therapies in the Contemporary EraChristopher M Lopez, Jose F Suarez, Maria A Mendoza, et al.
Nature Immunology|October 24, 2007
CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanismsMatthew J Dolan, Hemant Kulkarni, Jose F Camargo, et al.
Pageof 6